Since proline has a major impact on energy metabolism, glycolysis, the redox state, apoptosis and proliferation of tumor cells, PYCR1 has been suggested as a therapeutic candidate target in many cancers [72,73,74] to which we now can add aggressive TETs. This evidence concerns the gene PYCR1 and neoplasm.